Angiotech Pharmaceuticals, Inc. (TSX: ANP; NASDAQ: ANPI) has sold certain Quill intellectual property to Ethicon, Inc., a unit of Johnson & Johnson, Inc., and its affiliates.
Angiotech will receive initial cash payment...
To Read This Article, Please Login or Subscribe
For $5 plus HST a month (recurring), you will have access to all our premium contents (database access is not included). For database subscription, please click here.
